Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Filter Content:
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Articles
Oncology
9
Mins
24th October 2017
Post-Surgical Strategies for Prostate Cancer: Clinicopathologic and Genomics Criteria
Radical prostatectomy is widely used as the primary modality of treatment for clinically localised prostate cancer.
Oncology
9
Mins
24th October 2017
Prognostic and Predictive Value of FDG-PET as an Aid in Oesophageal Cancer Management
FDG-PET is widely used for cancer staging before treatment and detection of recurrence during post-treatment surveillance.
Oncology
10
Mins
24th October 2017
Understanding the Microenvironment of Melanoma Cells for the Development of Target Drug Delivery Systems
Melanoma is the most aggressive and deadly form of skin cancer. The high rate of patient death is related to advanced melanoma metastasis, which usually…
Oncology
10
Mins
24th October 2017
Chemotherapy for Extracranial Germ Cell Tumours in Paediatric, Adolescent, and Young Adult Patients
Extracranial germ cell tumours are derived from dysregulated, unipotent to totipotent, primordial germ cells and can arise from heterogeneous sites and…
Oncology
9
Mins
24th October 2017
Malignant Pleural Mesothelioma: Spotlight on Recent Advances in Diagnosis and Treatment
Pleural malignancies constitute either primary pleural malignancies, such as malignant pleural mesothelioma (MPM), or secondary pleural tumours, either…
Innovations
4
Mins
18th October 2017
Healthcare Reform: When Do We Need It and How?
Dr Maxine Szramka is a Rheumatologist in Sydney Australia. She blogs regularly at Dr Maxine Speaks10 and is a passionate advocate for the health and…
Oncology
3
Mins
12th October 2017
How to Play an Important Role in Raising Awareness for Mesothelioma in Health Education Week
Blue is the colour of hope that brings a broader awareness to a rare cancer called mesothelioma.
Cardiology
7
Mins
12th October 2017
Editor’s Pick: Protecting the Heart in Cancer Patients: The Role of Cardio-Oncology
Cardiac disease often impacts cancer therapy, from direct toxicity of cancer therapeutic agents to the coronary endothelium, the myocardium, heart valves…
Loading posts...
« Previous
1
…
155
156
157
158
159
…
247
Next »